{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:25:06Z","timestamp":1787678706884,"version":"build-2784847793"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Society of Hypertension"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.jash.2011.02.004","type":"journal-article","created":{"date-parts":[[2011,4,15]],"date-time":"2011-04-15T11:42:18Z","timestamp":1302867738000},"page":"128-136","source":"Crossref","is-referenced-by-count":40,"title":["Hypertension in peritoneal dialysis patients: epidemiology, pathogenesis, and treatment"],"prefix":"10.1016","volume":"5","author":[{"given":"Luis M.","family":"Ortega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry J.","family":"Materson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jash.2011.02.004_bib1","series-title":"Nolph and Gokal\u2019s Textbook of Peritoneal Dialysis","first-page":"3","article-title":"History of peritoneal dialysis","author":"Negoi","year":"2009"},{"key":"10.1016\/j.jash.2011.02.004_bib2","unstructured":"United States Renal Data System. 2010 Annual Data Report, volume 2. 2010 Atlas of End-Stage Renal Disease in the United States. p 26, Figure\u00a05."},{"key":"10.1016\/j.jash.2011.02.004_bib3","series-title":"Nolph and Gokal\u2019s Textbook of Peritoneal Dialysis","first-page":"21","article-title":"Currents status of peritoneal dialysis","author":"Mehrotra","year":"2009"},{"key":"10.1016\/j.jash.2011.02.004_bib4","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.108.125674","article-title":"Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial","volume":"53","author":"Agarwal","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2011.02.004_bib5","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0272-6386(01)80017-2","article-title":"Strict volume control normalizes hypertension in peritoneal dialysis patients","volume":"37","author":"G\u00fcnal","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jash.2011.02.004_bib6","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.2215\/CJN.00110108","article-title":"Age-related blood pressure patterns and blood pressure variability among hemodialysis patients","volume":"3","author":"Rohrscheib","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jash.2011.02.004_bib7","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1681\/ASN.V12102158","article-title":"Churchill DN for the CANUSA Peritoneal Dialysis Study Group. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study","volume":"12","author":"Bargman","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jash.2011.02.004_bib8","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1093\/ndt\/gfp313","article-title":"Preserving residual renal function in peritoneal dialysis: volume or biocompatibility?","volume":"24","author":"Davies","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jash.2011.02.004_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/089686080102100108","article-title":"Preservation of residual renal function in dialysis patients: effects of dialysis-technique-related factors","volume":"21","author":"Lang","year":"2001","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.jash.2011.02.004_bib10","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1093\/ndt\/gfp056","article-title":"Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long-term peritoneal dialysis","volume":"24","author":"Liao","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jash.2011.02.004_bib11","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/ndt\/14.6.1536","article-title":"Prevalence of hypertension in patients on peritoneal dialysis: results of an Italian multicentre study","volume":"14","author":"Cocchi","year":"1999","journal-title":"Nephrol Dial Transplant"},{"issue":"suppl\u00a02","key":"10.1016\/j.jash.2011.02.004_bib12","doi-asserted-by":"crossref","first-page":"S138","DOI":"10.1177\/089686089901902S22","article-title":"Hypertension in a continuous ambulatory peritoneal dialysis patient: what do we know and what can we do about it?","volume":"19","author":"Cheigh","year":"1999","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.jash.2011.02.004_bib13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.ajkd.2008.08.030","article-title":"Blood pressure and mortality risk on peritoneal dialysis","volume":"53","author":"Udayaraj","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jash.2011.02.004_bib14","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1093\/ndt\/16.11.2207","article-title":"Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function","volume":"16","author":"Menon","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jash.2011.02.004_bib15","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1046\/j.1523-1755.1999.00353.x","article-title":"Mortality and technique failure in patients starting chronic peritoneal dialysis: results of the Netherlands Cooperative Study on the Adequacy of Dialysis","volume":"55","author":"Jager","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.jash.2011.02.004_bib16","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1093\/ndt\/gfh856","article-title":"The association between BP and mortality in patients on chronic peritoneal dialysis","volume":"20","author":"Goldfarb-Rumyantzev","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jash.2011.02.004_bib17","first-page":"49","article-title":"Hypotension in patients on chronic peritoneal dialysis: etiology, management, and outcome","volume":"18","author":"Malliara","year":"2002","journal-title":"Adv Perit Dial"},{"key":"10.1016\/j.jash.2011.02.004_bib18","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/089686080202200406","article-title":"Fluid status, blood pressure, and cardiovascular abnormalities in patients on peritoneal dialysis","volume":"22","author":"Konings","year":"2002","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.jash.2011.02.004_bib19","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1046\/j.1525-139x.2000.00051.x","article-title":"Pathogenic effects of a high peritoneal transport rate","volume":"13","author":"Heaf","year":"2000","journal-title":"Semin Dial"},{"key":"10.1016\/j.jash.2011.02.004_bib20","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1001\/archinte.1996.00440060016002","article-title":"Renal parenchymal hypertension: current concepts of pathogenesis and management","volume":"156","author":"Preston","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jash.2011.02.004_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000182927","article-title":"Permanent loss of ultrafiltration capacity of the peritoneum in long-term peritoneal dialysis: an epidemiological study","volume":"33","author":"Slingeneyer","year":"1983","journal-title":"Nephron"},{"key":"10.1016\/j.jash.2011.02.004_bib22","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3747\/pdi.2008.00284","article-title":"Body composition, hydration, and related parameters in hemodialysis versus peritoneal dialysis patients","volume":"30","author":"Devolder","year":"2010","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.jash.2011.02.004_bib23","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1093\/ndt\/gfh806","article-title":"A detailed analysis of sodium removal by peritoneal dialysis: comparison with predictions from the three-pore model of membrane function","volume":"20","author":"Aanen","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jash.2011.02.004_bib24","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1525-139X.2010.00739.x","article-title":"Achieving euvolemia in peritoneal dialysis patients: a surprisingly difficult proposition","volume":"23","author":"Tan","year":"2010","journal-title":"Semin Dial"},{"key":"10.1016\/j.jash.2011.02.004_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0272-6386(03)00420-7","article-title":"Measurement of intraperitoneal volume by segmental bioimpedance analysis during peritoneal dialysis","volume":"42","author":"Zhu","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jash.2011.02.004_bib26","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1744-9987.2007.00416.x","article-title":"Hypoalbuminemia is also a marker of fluid excess determined by bioelectrical impedance parameters in dialysis patients","volume":"11","author":"Cigarran","year":"2007","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.jash.2011.02.004_bib27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/j.ajkd.2004.03.035","article-title":"Compared time profiles of ultrafiltration, sodium removal, and renal function in incident CAPD and automated peritoneal dialysis patients","volume":"44","author":"Rodriguez-Carmona","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jash.2011.02.004_bib28","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1177\/089686080202200610","article-title":"Sodium removal in patients undergoing CAPD and automated peritoneal dialysis","volume":"22","author":"Rodriguez-Carmona","year":"2002","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.jash.2011.02.004_bib29","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/089686080002000414","article-title":"Left ventricular hypertrophy and clinical outcome in CAPD patients","volume":"20","author":"Silaruks","year":"2000","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.jash.2011.02.004_bib30","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/ndt\/14.9.2178","article-title":"Association of hyperphosphataemia with haemodynamic disturbances in end-stage renal disease","volume":"14","author":"Marchais","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jash.2011.02.004_bib31","article-title":"Dietary phosphate restriction in dialysis patients: a new approach for the treatment of hyperphosphataemia","author":"Guida","year":"2010","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jash.2011.02.004_bib32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000245640","article-title":"Phosphate elimination in modalities of hemodialysis and peritoneal dialysis","volume":"29","author":"Kuhlmann","year":"2010","journal-title":"Blood Purif"},{"key":"10.1016\/j.jash.2011.02.004_bib33","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/ki.2009.469","article-title":"Blood pressure in chronic kidney disease stage 5D\u2014report from a Kidney Disease: Improving Global Outcomes controversies conference","volume":"77","author":"Levin","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.jash.2011.02.004_bib34","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/ndt\/15.6.862","article-title":"Effects of icodextrin in automated peritoneal dialysis on blood pressure and bioelectrical impedance analysis","volume":"15","author":"Woodrow","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jash.2011.02.004_bib35","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1097\/01.ASN.0000083904.12234.27","article-title":"Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial","volume":"14","author":"Davies","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"S3","key":"10.1016\/j.jash.2011.02.004_bib36","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1177\/089686080502503S16","article-title":"Initiating CAPD with a regimen low in glucose and glucose degradation products, with icodextrin and amino acids (NEPP) is safe and efficacious","volume":"25","author":"Poole","year":"2005","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.jash.2011.02.004_bib37","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/ndt\/gfg147","article-title":"Fluid status in CAPD patients is related to peritoneal transport and residual renal function: evidence from a longitudinal study","volume":"18","author":"Konings","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jash.2011.02.004_bib38","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/ndt\/17.9.1661","article-title":"Uncontrolled hypertension due to volume overload contributes to higher left ventricular mass index in CAPD patients","volume":"17","author":"Koc","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jash.2011.02.004_bib39","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1681\/ASN.V881311","article-title":"Commonly prescribed salt intake in continuous ambulatory peritoneal dialysis is too restrictive: results of a double-blind crossover study","volume":"8","author":"Fine","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jash.2011.02.004_bib40","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1053\/j.ajkd.2003.08.028","article-title":"Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients","volume":"42","author":"Griffith","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jash.2011.02.004_bib41","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1046\/j.1523-1755.2002.00355.x","article-title":"Calcium channel blocker use and mortality among patients with end-stage renal disease","volume":"61","author":"Kestenbaum","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.jash.2011.02.004_bib42","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1053\/ajkd.2002.36340","article-title":"ACE inhibitors and survival of hemodialysis patients","volume":"40","author":"Efrati","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jash.2011.02.004_bib43","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1046\/j.1523-1755.2001.0590031128.x","article-title":"Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis","volume":"59","author":"Medcalf","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.jash.2011.02.004_bib44","first-page":"51","article-title":"High intraperitoneal furosemide doses in long-dwell exchange","volume":"4","author":"Grzegorzewska","year":"1988","journal-title":"Adv Perit Dial"},{"key":"10.1016\/j.jash.2011.02.004_bib45","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/089686080302300406","article-title":"Acute effects of high-dose furosemide on residual renal function in CAPD patients","volume":"23","author":"van Olden","year":"2003","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.jash.2011.02.004_bib46","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0272-6386(96)90380-7","article-title":"Prevalence of hypertension in 1,795 subjects with chronic renal disease: the Modification of Diet in Renal Disease study baseline cohort. Modification of Diet in Renal Disease Study Group","volume":"28","author":"Buckalew","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jash.2011.02.004_bib47","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-139-2-200307150-00010","article-title":"Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized controlled study","volume":"139","author":"Li","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jash.2011.02.004_bib48","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1053\/j.ajkd.2004.01.019","article-title":"Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD","volume":"43","author":"Suzuki","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jash.2011.02.004_bib49","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3747\/pdi.2009.00088","article-title":"Treatment with angiotensin II inhibitors and residual renal function in peritoneal dialysis patients","volume":"31","author":"Kolesnyk","year":"2011","journal-title":"Perit Dial Int"}],"container-title":["Journal of the American Society of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933171111000532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933171111000532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T18:51:51Z","timestamp":1637520711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933171111000532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S1933171111000532"],"URL":"https:\/\/doi.org\/10.1016\/j.jash.2011.02.004","relation":{},"ISSN":["1933-1711"],"issn-type":[{"value":"1933-1711","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}